Mitral repair · Decision guide
Compare the repair plan for your valve, the relevance of robotic surgery and the evidence that matters after discharge.
Mitral repair preserves a leaking native valve when a durable reconstruction is feasible. The lesion and cause of leakage determine the repair; robotic assistance changes the access and instruments rather than guaranteeing durability.
Primary leaflet disease and leakage secondary to heart-muscle changes follow different treatment pathways.
Sources: ESC/EACTS valve guidance (2025)
Minithoracotomy repair had a median five-day hospital stay versus six with sternotomy, without superior physical function at 12 weeks.
Sources: UK Mini Mitral trial · JAMA (2023)
This is a starting figure for mitral repair, not an itemised named-surgeon package.
Sources: Mitral valve repair in Turkey: displayed starting price, 8 October 2026
Free Bookimed support. Compare options before deciding.
Sources: ESC/EACTS valve guidance (2025)
Sources: ESC/EACTS valve guidance (2025) · NHS: valve types
Primary regurgitation involves the valve apparatus itself. Secondary regurgitation follows changes in the ventricle or atrium and may need a different treatment pathway. A prolapsing leaflet, a complex bileaflet valve and SAM associated with HCM should not all be treated as the same repair problem.
Sources: ESC/EACTS valve guidance (2025) · 2024 HCM guideline: official teaching slides
A high repair rate in selected straightforward cases is not a forecast for a complex valve. Our evidence comparisons retain the lesion mix and follow-up behind each figure.
| Feature | Why it changes the choice |
|---|---|
| Leaflet and chordal anatomy | Determines the reconstruction needed and the feasibility of durable repair |
| Durability | Recurrent moderate/severe leakage and repeat surgery are different outcomes from an initial successful repair |
| Access | Robotic or smaller-incision surgery must deliver the same intended reconstruction |
| Replacement fallback | A valve that cannot be adequately repaired may require a prosthesis with long-term trade-offs |
Sources: ESC/EACTS valve guidance (2025) · UK Mini Mitral trial · JAMA (2023)
Robotic assistance is an access and instrument choice. It does not itself identify a more durable repair. The UK Mini Mitral randomized trial compared minithoracotomy with sternotomy in degenerative repair: median hospital stay was 5 versus 6 days, while the primary physical-function result at 12 weeks did not establish superiority. This was not a robotic-versus-open trial.
Sources: UK Mini Mitral trial · JAMA (2023)
If durable repair is not feasible, valve replacement is an alternative. Mechanical valves require lifelong anticoagulation; tissue valves may deteriorate and need another intervention. TEER is a separate catheter treatment for selected patients, including some with symptomatic severe secondary regurgitation despite optimized heart-failure care.
Sources: ESC/EACTS valve guidance (2025) · NHS: valve types
Bookimed’s Turkey mitral-repair listing displayed a starting price of USD 14,900 on 8 October 2026. This is a listing-level starting figure; it does not specify a complete individual repair package or establish what a named surgeon will charge.
Repair can involve an annuloplasty ring, artificial chordae or other reconstruction. These materials differ from a replacement prosthesis. Access route, combined procedures and length of hospital care also affect the price; a valve-replacement package does not establish the price of repair.
| Your quote should name | Why it matters |
|---|---|
| Planned repair and materials | Clarifies the operative scope instead of using a generic heart-valve label |
| Possible replacement | Explains consent, valve choice and financial terms if the plan changes |
| Access and combined procedures | Separates isolated repair from a combined or different operation |
| Hospital and follow-up care | Makes additional nights, rehabilitation and later echocardiography comparable |
Sources: Mitral valve repair in Turkey: displayed starting price, 8 October 2026 · ESC/EACTS valve guidance (2025)
Keeping the native valve is valuable only if it functions well over time. Follow-up echocardiography tracks leakage, while clinical review tracks symptoms and activity. Those outcomes are more informative than the incision alone.
Sources: ESC/EACTS valve guidance (2025) · UK Mini Mitral trial · JAMA (2023)
Explore each specialist’s clinical focus, current programme and the studies relevant to this treatment. The listed roles include cardiac surgeons and, where appropriate, interventional cardiologists.
Cleveland, Ohio · United States
cardiac surgeon
Gillinov’s Cleveland Clinic practice includes mitral repair and robotic mitral surgery.
Sources: A. Marc Gillinov, MD | Cleveland Clinic · Early results of robotically assisted mitral valve surgery: Analysis of the first 1000 cases
Chicago · United States
cardiac surgeon
Balkhy performs robotic mitral valve surgery at UChicago Medicine, including complex repair. In the hospital’s reported bileaflet case, his team used artificial chordae and an annuloplasty ring.
Sources: Husam H. Balkhy, MD
Tokyo · Japan
cardiac surgeon
Watanabe’s NewHeart team has published robotic repair of complex Barlow valves using artificial chordae and selective leaflet resection.
Sources: Outcomes of Barlow mitral valve repaired by robot-assisted keyhole surgery. · Robot-assisted surgery and team profiles
Los Angeles · United States
cardiac surgeon
Chikwe’s Cedars-Sinai work includes robotic repair of degenerative mitral valves and complex Barlow disease. Her programme’s studies follow recurrent leakage as well as whether the valve was repaired.
Sources: Joanna Chikwe clinical profile · Eliminating the learning curve in robotic mitral valve repair: Results from 1400 patients. · Robotic repair for Barlow mitral regurgitation: Repairability, safety, and durability.
Continue your guide
Free Bookimed support. Compare options before deciding.
Free Bookimed support. Compare options before deciding.
